Jonas Lannergård

604 total citations
14 papers, 450 citations indexed

About

Jonas Lannergård is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jonas Lannergård has authored 14 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Jonas Lannergård's work include Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Neonatal and Maternal Infections (6 papers). Jonas Lannergård is often cited by papers focused on Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Neonatal and Maternal Infections (6 papers). Jonas Lannergård collaborates with scholars based in Sweden, Denmark and United Kingdom. Jonas Lannergård's co-authors include Diarmaid Hughes, Bengt Guss, Jan‐Ingmar Flock, Margareta Flock, Gunnar Lindahl, Margaretha Stålhammar‐Carlemalm, Mattias C. U. Gustafsson, Georg Peters, Gunnar Sander and Karsten Becker and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Jonas Lannergård

14 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Lannergård Sweden 12 243 197 184 72 65 14 450
Ravin Seepersaud United States 15 127 0.5× 231 1.2× 233 1.3× 59 0.8× 157 2.4× 25 551
Olivia N. Chuang-Smith United States 9 312 1.3× 215 1.1× 109 0.6× 52 0.7× 118 1.8× 10 504
Kellie Burnside United States 14 217 0.9× 250 1.3× 298 1.6× 91 1.3× 248 3.8× 17 721
Romain Guérillot Australia 12 224 0.9× 259 1.3× 49 0.3× 69 1.0× 65 1.0× 23 487
Belinda Modun United Kingdom 7 175 0.7× 241 1.2× 55 0.3× 58 0.8× 46 0.7× 8 436
Christy L. Ventura United States 12 199 0.8× 285 1.4× 71 0.4× 79 1.1× 129 2.0× 16 518
Santiago M. Lattar Argentina 11 341 1.4× 288 1.5× 45 0.2× 88 1.2× 82 1.3× 14 502
René Bergmann Germany 12 120 0.5× 114 0.6× 177 1.0× 40 0.6× 49 0.8× 24 345
Elizabeth A. Ohneck United States 7 247 1.0× 213 1.1× 45 0.2× 125 1.7× 33 0.5× 7 402
Nobuhiro Iwakura Japan 11 241 1.0× 291 1.5× 72 0.4× 18 0.3× 32 0.5× 16 470

Countries citing papers authored by Jonas Lannergård

Since Specialization
Citations

This map shows the geographic impact of Jonas Lannergård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Lannergård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Lannergård more than expected).

Fields of papers citing papers by Jonas Lannergård

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Lannergård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Lannergård. The network helps show where Jonas Lannergård may publish in the future.

Co-authorship network of co-authors of Jonas Lannergård

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Lannergård. A scholar is included among the top collaborators of Jonas Lannergård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Lannergård. Jonas Lannergård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pawłowski, A, Jonas Lannergård, Duojia Cao, et al.. (2022). A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains. Cell Reports Medicine. 3(2). 100511–100511. 23 indexed citations
2.
Lannergård, Jonas, Mattias C. U. Gustafsson, Jenny Persson, et al.. (2015). Sequence variability is correlated with weak immunogenicity in Streptococcus pyogenes M protein. MicrobiologyOpen. 4(5). 774–789. 11 indexed citations
3.
Gustafsson, Mattias C. U., Jonas Lannergård, John Elmerdahl Olsen, et al.. (2013). Factor H Binds to the Hypervariable Region of Many Streptococcus pyogenes M Proteins but Does Not Promote Phagocytosis Resistance or Acute Virulence. PLoS Pathogens. 9(4). e1003323–e1003323. 35 indexed citations
4.
Lannergård, Jonas, et al.. (2013). Affinity Purification of Human Factor H on Polypeptides Derived from Streptococcal M Protein: Enrichment of the Y402 Variant. PLoS ONE. 8(11). e81303–e81303. 3 indexed citations
5.
Lannergård, Jonas, et al.. (2011). The Hypervariable Region of Streptococcus pyogenes M Protein Escapes Antibody Attack by Antigenic Variation and Weak Immunogenicity. Cell Host & Microbe. 10(2). 147–157. 37 indexed citations
6.
Lannergård, Jonas, et al.. (2011). Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus. PLoS ONE. 6(11). e28366–e28366. 23 indexed citations
7.
Lannergård, Jonas, et al.. (2009). Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(5). 2059–2065. 48 indexed citations
8.
Lannergård, Jonas, Christof von Eiff, Gunnar Sander, et al.. (2008). Identification of the Genetic Basis for Clinical Menadione-Auxotrophic Small-Colony Variant Isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52(11). 4017–4022. 86 indexed citations
9.
Waller, Andrew S., Margareta Flock, Ken Smith, et al.. (2007). Vaccination of horses against strangles using recombinant antigens from Streptococcus equi. Vaccine. 25(18). 3629–3635. 27 indexed citations
10.
Lannergård, Jonas, Anja Kassner, Dick Heinegård, et al.. (2007). A Secreted Collagen- and Fibronectin-binding Streptococcal Protein Modulates Cell-mediated Collagen Gel Contraction and Interstitial Fluid Pressure. Journal of Biological Chemistry. 283(3). 1234–1242. 15 indexed citations
11.
Lannergård, Jonas, et al.. (2007). Genetic and Phenotypic Identification of Fusidic Acid-Resistant Mutants with the Small-Colony-Variant Phenotype in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 51(12). 4438–4446. 83 indexed citations
12.
Flock, Margareta, Åsa Karlström, Jonas Lannergård, Bengt Guss, & Jan‐Ingmar Flock. (2006). Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse. Vaccine. 24(19). 4144–4151. 25 indexed citations
13.
Karlström, Åsa, Jonas Lannergård, Sebastian Kalamajski, et al.. (2005). A fibronectin-binding protein from Streptococcus equi binds collagen and modulates cell-mediated collagen gel contraction. Biochemical and Biophysical Research Communications. 340(2). 604–610. 9 indexed citations
14.
Lannergård, Jonas, Margareta Flock, Staffan Johansson, Jan‐Ingmar Flock, & Bengt Guss. (2005). Studies of Fibronectin-Binding Proteins of Streptococcus equi. Infection and Immunity. 73(11). 7243–7251. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026